(Q39909171)

English

Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals

scientific article published in December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Barrie March

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tara Cardi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1807-1815

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve.

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Dose comparison trial of sustained-release fampridine in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Inhibition of HERG K+ Current and Prolongation of the Guinea‐Pig Ventricular Action Potential by 4‐Aminopyridine

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Effects of 4-aminopyridine on cardiac repolarization, PR interval, and heart rate in patients with spinal cord injury

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

4-Aminopyridine in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1517%2F13543780903443096

21 January 2018

Identifiers

10.1517/13543780903443096

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

release_yw7v5t2fkrbylbalcyog6mccou

1 reference

https://api.fatcat.wiki/v0/release/yw7v5t2fkrbylbalcyog6mccou

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39909171&oldid=1876826163"